Lantheus Holdings Operating Cash Flow 2011-2026 | LNTH

Annual Operating Cash Flow Lantheus Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
390 M	545 M	305 M	282 M	53.9 M	16.4 M	80.4 M	61.2 M	54.8 M	49.6 M	21.8 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
545 M	16.4 M	169 M

Quarterly Operating Cash Flow Lantheus Holdings

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
125 M	-	-	108 M	-	-	-	127 M	-	-	-	108 M	-	176 M	-	10.3 M	-	40 M	-	9.82 M	-	15.8 M	7.25 M	9.41 M	-	58 M	31.5 M	10.5 M	-	43.9 M	19.6 M	-666 K	-	41.7 M	26.1 M	5.52 M	-	36.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
176 M	-666 K	48.1 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Agilent Technologies A	1.48 B	$ 135.53	0.11 %	$ 41.2 B	USA
Celcuity CELC	-153 M	$ 132.88	1.5 %	$ 6.21 B	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	-29.1 M	$ 8.53	-23.77 %	$ 11.3 M	USA
Castle Biosciences CSTL	64.3 M	$ 21.08	-4.66 %	$ 611 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-24.2 M	-	-61.36 %	$ 2.46 M	USA
Fulgent Genetics FLGT	-102 M	$ 18.14	-0.55 %	$ 558 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	-185 M	$ 129.69	-2.65 %	$ 16.3 B	USA
CareDx, Inc CDNA	42 M	$ 22.82	0.53 %	$ 1.22 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
ICON Public Limited Company ICLR	1.04 B	$ 136.07	-0.53 %	$ 10.7 B	Irlanda
Check-Cap Ltd. CHEK	-46 K	-	-	$ 9.42 M	Israel
Interpace Biosciences IDXG	5.83 M	$ 1.7	-5.56 %	$ 7.52 M	USA
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	837 M	$ 162.96	2.68 %	$ 25.9 B	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-9.68 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	956 M	$ 1 180.58	1.47 %	$ 24.3 B	Schweiz
Charles River Laboratories International CRL	738 M	$ 180.71	-0.35 %	$ 8.96 B	USA
NeoGenomics NEO	5.23 M	$ 10.52	3.24 %	$ 1.35 B	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
National Research Corporation NRC	26.4 M	$ 19.53	-0.66 %	$ 437 M	USA
Natera NTRA	-432 M	$ 223.37	4.41 %	$ 22 B	USA
Medpace Holdings MEDP	713 M	$ 447.11	-0.23 %	$ 12.9 B	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	1.8 M	$ 3.97	-5.92 %	$ 368 M	USA
Personalis PSNL	-74.9 M	$ 11.4	3.83 %	$ 1.02 B	USA
Senseonics Holdings SENS	-59.1 M	$ 6.79	1.04 %	$ 283 M	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	46.8 M	-	-	$ 2.69 B	USA
Twist Bioscience Corporation TWST	-47.6 M	$ 66.87	-3.13 %	$ 4 B	USA
Biomerica BMRA	-3.84 M	$ 2.39	-1.74 %	$ 5.49 M	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 260.06	-0.75 %	$ 21.6 B	USA
Thermo Fisher Scientific TMO	7.82 B	$ 492.51	1.09 %	$ 186 B	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.7	-0.16 %	$ 251 M	Irlanda
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	58.2 M	$ 8.97	-3.55 %	$ 1.95 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 194.9	-0.72 %	$ 21.6 B	USA
Invitae Corporation NVTA	-493 M	-	-	$ 21.2 M	USA